Sunesis Pharmaceuticals (SNSS)

5.46 +0.05  +0.92%  May 17, 8:00PM
Add to Watchlists Create an Alert

Sunesis Pharmaceuticals Debt to Equity Ratio:

2.029 for Dec. 31, 2012
View Full Chart

Sunesis Pharmaceuticals Debt to Equity Ratio Chart

    Sunesis Pharmaceuticals Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.029
    Sept. 30, 2012 2.407
    June 30, 2012 1.358
    March 31, 2012 0.6501
    Dec. 31, 2011 0.3374
    Sept. 30, 2011 0.00
    June 30, 2011 0.00
    March 31, 2011 0.00
    Dec. 31, 2010 0.00
    Sept. 30, 2010 0.00
    June 30, 2010 0.00
    March 31, 2010 0.00
    Dec. 31, 2009 0.00
    Sept. 30, 2009 0.00
    June 30, 2009 0.00
       
    March 31, 2009
    Dec. 31, 2008 0.00
    Sept. 30, 2008 0.1196
    June 30, 2008 0.0906
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    SNSS Debt to Equity Ratio Benchmarks

    Companies
    Repligen Corporation 0.00
    Curis 0.00
    Cell Therapeutics 0.7804

    SNSS Debt to Equity Ratio Rankings

    Overall 45th percentile
    4350 of 8007
    Sector 25th percentile
    511 of 685 in Healthcare
    Industry 28th percentile
    178 of 248 in Biotechnology

    SNSS Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.00 Dec 2008
    Maximum 2.407 Sep 2012
    Average 0.3884